Medexus Pharmaceuticals (MDP) Stock Chart & Stock Price History C$3.03 +0.01 (+0.33%) As of 10:27 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesBuy This Stock Medexus Pharmaceuticals Stock Price Performance The Medexus Pharmaceuticals (MDP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 30.04%, with a year-to-date return of -12.43%. In the past month, the stock has increased 2.71%, reflecting recent market activity. As of the latest close, Medexus Pharmaceuticals traded at C$3.02 with a market cap of C$97.42 million and volume of 24,196 shares. Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-2.26%1 Month Performance+2.71%3 Month Performance+1.00%Year-To-Date Performance-12.43%1 Year Performance+30.04% MDP Stock Chart for Tuesday, September, 16, 2025 MDP Chart by TradingView Medexus Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/15/2025C$3.03C$3.02-0.33%C$3.06C$2.9724,196 shsC$97.42 million09/12/2025C$3.10C$3.03-2.26%C$3.13C$3.0323,710 shsC$97.74 million09/11/2025C$3.11C$3.10-0.32%C$3.12C$3.0812,730 shsC$100 million09/10/2025C$3.07C$3.11+1.30%C$3.12C$3.0819,375 shsC$100.32 million09/09/2025C$3.12C$3.07-1.60%C$3.15C$3.0614,254 shsC$99.03 million09/08/2025C$3.08C$3.12+1.30%C$3.26C$3.0885,980 shsC$100.65 million09/05/2025C$3.05C$3.08+0.98%C$3.12C$3.0120,200 shsC$99.36 million09/04/2025C$3.07C$3.05-0.65%C$3.07C$3.0329,523 shsC$98.39 million09/03/2025C$3.05C$3.07+0.66%C$3.11C$3.0719,838 shsC$99.03 million09/02/2025C$3.05C$3.05C$3.12C$2.9953,050 shsC$98.39 million Get the Latest News and Ratings for MDP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 09/01/2025C$3.05C$3.05C$3.10C$3.0125,500 shsC$98.39 million08/29/2025C$3.11C$3.05-1.93%C$3.10C$3.0125,500 shsC$68.28 million08/28/2025C$3.11C$3.11C$3.19C$3.0558,147 shsC$69.63 million08/27/2025C$2.85C$3.11+9.12%C$3.19C$2.81197,547 shsC$69.63 million08/26/2025C$2.85C$2.85C$2.88C$2.7639,304 shsC$63.81 million08/25/2025C$2.87C$2.85-0.70%C$2.90C$2.8061,022 shsC$63.81 million08/22/2025C$2.85C$2.87+0.70%C$2.90C$2.8526,279 shsC$64.25 million08/21/2025C$2.96C$2.85-3.72%C$2.99C$2.8240,854 shsC$63.81 million08/20/2025C$2.81C$2.96+5.34%C$2.99C$2.8242,067 shsC$66.27 million08/19/2025C$2.85C$2.81-1.40%C$2.82C$2.7323,070 shsC$62.91 million08/18/2025C$2.95C$2.85-3.39%C$2.93C$2.7680,844 shsC$63.81 million08/15/2025C$2.75C$2.95+7.27%C$2.95C$2.7945,719 shsC$66.05 million Related Companies Aurora Cannabis Stock Chart SugarBud Craft Growers Stock Chart Organigram Stock Chart HLS Therapeutics Stock Chart BioSyent Stock Chart Cardiol Therapeutics Stock Chart Decibel Cannabis Stock Chart MediPharm Labs Stock Chart Voyageur Pharmaceuticals Stock Chart Willow Biosciences Stock Chart Receive MDP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Medexus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:MDP) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
